Mycobacterium Infections, Nontuberculous Clinical Trial
Official title:
A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex
The purpose of this study is to evaluate the efficacy, safety and tolerability of oral omadacycline as compared to placebo in the treatment of adults with Nontuberculous Mycobacterial (NTM) pulmonary disease caused by Mycobacterium abscessus complex (MABc)
The total duration of subject participation in the study is approximately 5 months which includes a total duration of study treatment for approximately 3 months (84 days). Eligible participants will be randomized 1.5:1 to receive 3 months of treatment with either omadacycline or placebo (monotherapy). The study will use a double-dummy design in order to maintain the study blinding. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03038178 -
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease
|
Phase 2 | |
| Terminated |
NCT04154826 -
Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease
|
Phase 2 | |
| Completed |
NCT02344004 -
Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
|
Phase 3 | |
| Recruiting |
NCT06266442 -
M. Avium WGS During Mav-PD Treatment
|
||
| Recruiting |
NCT02355015 -
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections
|
N/A | |
| Completed |
NCT03421743 -
Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection
|
Phase 2 | |
| Not yet recruiting |
NCT06418711 -
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
|
Phase 3 | |
| Terminated |
NCT03597347 -
Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection
|
Phase 2 | |
| Completed |
NCT02832843 -
Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease
|
||
| Completed |
NCT04677543 -
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
|
Phase 3 | |
| Completed |
NCT02340897 -
Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT
|
N/A | |
| Completed |
NCT01315236 -
Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria
|
Phase 2 | |
| Recruiting |
NCT04677569 -
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
|
Phase 3 |